Rafferty Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.58M | Sell |
99,066
-39,026
| -28% | -$3.74M | 0.03% | 265 |
|
|
2025
Q4 | $13.3M | Sell |
138,092
-4,127
| -3% | -$401K | 0.05% | 226 |
|
|
2025
Q3 | $13.5M | Buy |
142,219
+6,648
| +5% | +$611K | 0.04% | 230 |
|
|
2025
Q2 | $11.8M | Buy |
135,571
+16,842
| +14% | +$1.43M | 0.04% | 244 |
|
|
2025
Q1 | $10.7M | Sell |
118,729
-26,716
| -18% | -$2.39M | 0.05% | 252 |
|
|
2024
Q4 | $11.6M | Buy |
145,445
+15,357
| +12% | +$1.33M | 0.04% | 263 |
|
|
2024
Q3 | $11.7M | Sell |
130,088
-14,322
| -10% | -$1.2M | 0.04% | 258 |
|
|
2024
Q2 | $11.4M | Buy |
144,410
+7,175
| +5% | +$588K | 0.04% | 260 |
|
|
2024
Q1 | $12M | Buy |
137,235
+1,798
| +1% | +$153K | 0.04% | 238 |
|
|
2023
Q4 | $11.2M | Sell |
135,437
-3,461
| -2% | -$264K | 0.05% | 246 |
|
|
2023
Q3 | $10.9M | Buy |
138,898
+10,202
| +8% | +$854K | 0.06% | 205 |
|
|
2023
Q2 | $11.3M | Buy |
128,696
+9,697
| +8% | +$835K | 0.06% | 184 |
|
|
2023
Q1 | $9.59M | Buy |
118,999
+4,645
| +4% | +$379K | 0.07% | 193 |
|
|
2022
Q4 | $8.89M | Buy |
114,354
+43,268
| +61% | +$3.51M | 0.07% | 216 |
|
|
2022
Q3 | $5.74M | Buy |
71,086
+38,537
| +118% | +$3.46M | 0.06% | 306 |
|
|
2022
Q2 | $2.92M | Sell |
32,549
-8,550
| -21% | -$866K | 0.03% | 400 |
|
|
2022
Q1 | $4.56M | Sell |
41,099
-4,135
| -9% | -$437K | 0.03% | 409 |
|
|
2021
Q4 | $4.68M | Buy |
45,234
+2,386
| +6% | +$276K | 0.02% | 408 |
|
|
2021
Q3 | $5.37M | Buy |
42,848
+14,999
| +54% | +$1.94M | 0.04% | 293 |
|
|
2021
Q2 | $3.46M | Buy |
27,849
+2,411
| +9% | +$303K | 0.02% | 462 |
|
|
2021
Q1 | $3M | Buy |
25,438
+3,252
| +15% | +$381K | 0.02% | 492 |
|
|
2020
Q4 | $2.6M | Sell |
22,186
-4,184
| -16% | -$461K | 0.03% | 366 |
|
|
2020
Q3 | $2.74M | Sell |
26,370
-8,639
| -25% | -$868K | 0.03% | 332 |
|
|
2020
Q2 | $3.21M | Buy |
35,009
+24,692
| +239% | +$2.37M | 0.05% | 255 |
|
|
2020
Q1 | $930K | Sell |
10,317
-25,880
| -71% | -$2.75M | 0.04% | 248 |
|
|
2019
Q4 | $4.11M | Buy |
36,197
+19,570
| +118% | +$2.15M | 0.06% | 158 |
|
|
2019
Q3 | $1.81M | Sell |
16,627
-7,271
| -30% | -$759K | 0.03% | 415 |
|
|
2019
Q2 | $2.33M | Buy |
23,898
+5,782
| +32% | +$528K | 0.04% | 340 |
|
|
2019
Q1 | $1.65M | Buy |
+18,116
| New | +$1.62M | 0.03% | 451 |
|
|
2018
Q4 | – | Sell |
-30,910
| Closed | -$3.04M | – | 681 |
|
|
2018
Q3 | $3.04M | Buy |
+30,910
| New | +$2.86M | 0.05% | 190 |
|
|
2018
Q1 | – | Sell |
-30,153
| Closed | -$2.44M | – | 713 |
|
|
2017
Q4 | $2.44M | Buy |
+30,153
| New | +$2.41M | 0.04% | 225 |
|
|
2015
Q3 | – | Sell |
-2,995
| Closed | -$222K | – | 585 |
|
|
2015
Q2 | $222K | Sell |
2,995
-3,631
| -55% | -$277K | 0.01% | 488 |
|
|
2015
Q1 | $517K | Buy |
+6,626
| New | +$502K | 0.04% | 332 |
|
Other funds holding MDT
VCM
VPM
Rafferty Asset Management's MDT Position: Q1 2026 in Review
Rafferty Asset Management reduced its Medtronic (MDT) stake by 28% in Q1 2026, selling an estimated $3.74M and leaving 99,066 shares worth $8.58M. The position accounts for 0.03% of the portfolio, ranked #265.
Rafferty Asset Management first reported a position in MDT in Q1 2015 and has held it in 33 quarters since. The position peaked at $13.5M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Rafferty Asset Management held 99,066 shares of Medtronic worth $8.58M as of Q1 2026.
- Rafferty Asset Management sold 39,026 Medtronic shares in Q1 2026, an estimated $3.74M.
- Medtronic made up 0.03% of Rafferty Asset Management's portfolio in Q1 2026, its #265 holding.
- Rafferty Asset Management first reported a position in Medtronic in Q1 2015 and has held it in 33 quarters since.
- Rafferty Asset Management's Medtronic position peaked at $13.5M in Q3 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.